Common Stock (Tables)
|
12 Months Ended |
Dec. 31, 2016 |
Equity [Abstract] |
|
Schedule of Common Stock |
Gross proceeds of $24.0 million and underwriting discounts and commissions and offering expenses of $1.6 million were allocated as follows:
|
|
|
|
|
|
Series B
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-funded
|
|
|
Series A
|
|
|
Series B
|
|
|
|
|
|
|
|
Common
|
|
|
Common
|
|
|
Common
|
|
|
|
Common
|
|
|
Stock
|
|
|
Stock
|
|
|
Stock
|
|
|
|
Stock
|
|
|
Warrants
|
|
|
Warrants
|
|
|
Warrants
|
|
Units Issued
|
|
|
5,559,866
|
|
|
|
1,340,538
|
|
|
|
2,779,933
|
|
|
|
670,269
|
|
Gross Proceeds (in thousands)
|
|
$
|
14,084
|
|
|
$
|
3,387
|
|
|
$
|
5,261
|
|
|
$
|
1,268
|
|
Underwriting discount and offering expense (in thousands)
|
|
$
|
885
|
|
|
$
|
213
|
|
|
$
|
428
|
|
|
$
|
103
|
|
|
Summary of Fair Value of Option Awards |
The estimated fair value of stock options granted in the respective periods was determined using the Black-Scholes option pricing model using the following weighted average assumptions:
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
Risk-free interest rates
|
|
|
1.51
|
%
|
|
|
1.76
|
%
|
|
|
1.83
|
%
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected life
|
|
5.3 years
|
|
|
5.8 years
|
|
|
5.9 years
|
|
Expected volatility
|
|
|
72
|
%
|
|
|
63
|
%
|
|
|
82
|
%
|
|
Summary of Share-Based Compensation Expense |
The results for the periods set forth below included stock-based compensation expense in the following expense categories of the consolidated statements of loss (in thousands):
|
|
Years ended
|
|
|
|
December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
Research and development
|
|
$
|
803
|
|
|
$
|
1,111
|
|
|
$
|
1,893
|
|
General and administrative
|
|
|
846
|
|
|
|
1,217
|
|
|
|
1,967
|
|
Total stock-based compensation
|
|
$
|
1,649
|
|
|
$
|
2,328
|
|
|
$
|
3,860
|
|
|
Summary of Stock Options Activity |
Stock option transactions and the number of stock options outstanding are summarized below:
|
|
Number of
|
|
|
Weighted
|
|
|
|
Optioned
|
|
|
Average
|
|
|
|
Common
|
|
|
Exercise
|
|
|
|
Shares
|
|
|
Price
|
|
Balance, January 1, 2014
|
|
|
1,007,491
|
|
|
$
|
11.39
|
|
Granted
|
|
|
382,097
|
|
|
|
8.97
|
|
Expired
|
|
|
(12,169
|
)
|
|
|
18.93
|
|
Exercised
|
|
|
(10,000
|
)
|
|
|
3.00
|
|
Forfeited
|
|
|
(84,000
|
)
|
|
|
12.14
|
|
Balance, December 31, 2014
|
|
|
1,283,419
|
|
|
$
|
10.55
|
|
Granted
|
|
|
502,047
|
|
|
|
1.91
|
|
Expired
|
|
|
(247,766
|
)
|
|
|
2.96
|
|
Exercised
|
|
|
(5,359
|
)
|
|
|
2.69
|
|
Forfeited
|
|
|
(53,120
|
)
|
|
|
14.37
|
|
Balance, December 31, 2015
|
|
|
1,479,221
|
|
|
$
|
8.78
|
|
Granted
|
|
|
1,635,250
|
|
|
|
0.86
|
|
Expired
|
|
|
(994,059
|
)
|
|
|
1.00
|
|
Exercised
|
|
|
—
|
|
|
|
—
|
|
Forfeited
|
|
|
(741,607
|
)
|
|
|
1.96
|
|
Balance, December 31, 2016
|
|
|
1,378,805
|
|
|
$
|
8.62
|
|
|
Summary of Stock Options Outstanding Regarding Number of Common Shares Issuable upon Exercise of Outstanding Options |
(1) Number of common shares issuable upon exercise of outstanding options:
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
|
|
|
|
|
Weighted-
|
|
|
Contractual
|
|
|
|
|
|
|
|
Average
|
|
|
Life
|
|
Exercise Prices
|
|
Number of Options
|
|
|
Exercise Price
|
|
|
(in years)
|
|
$1.00 - $1.54
|
|
|
122,010
|
|
|
$
|
1.00
|
|
|
|
9.36
|
|
$1.55 - $1.88
|
|
|
337,298
|
|
|
|
1.86
|
|
|
|
7.96
|
|
$1.89 - $3.40
|
|
|
118,874
|
|
|
|
2.62
|
|
|
|
6.98
|
|
$3.41 - $11.70
|
|
|
78,447
|
|
|
|
7.70
|
|
|
|
5.72
|
|
$11.71 - $11.86
|
|
|
185,105
|
|
|
|
11.79
|
|
|
|
6.66
|
|
$11.87 - $11.99
|
|
|
144,699
|
|
|
|
11.95
|
|
|
|
5.64
|
|
$12.00- $13.08
|
|
|
132,650
|
|
|
|
12.88
|
|
|
|
4.97
|
|
$13.09 - $16.40
|
|
|
135,576
|
|
|
|
15.64
|
|
|
|
3.54
|
|
$16.41 - $21.67
|
|
|
63,446
|
|
|
|
17.74
|
|
|
|
3.56
|
|
$21.68 - $22.28
|
|
|
60,700
|
|
|
|
22.28
|
|
|
|
2.67
|
|
|
|
|
1,378,805
|
|
|
$
|
8.62
|
|
|
|
6.30
|
|
|
Summary of Stock Options Outstanding Regarding Number of Common Shares Issuable upon Exercise of Vested Options |
(2) Number common shares issuable upon exercise of vested options:
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
|
|
|
|
|
Weighted-
|
|
|
Contractual
|
|
|
|
|
|
|
|
Average
|
|
|
Life
|
|
Exercise Prices
|
|
Number of Options
|
|
|
Exercise Price
|
|
|
(in years)
|
|
$1.00 - $1.54
|
|
|
510
|
|
|
$
|
1.21
|
|
|
|
0.42
|
|
$1.55 - $1.88
|
|
|
184,008
|
|
|
|
1.86
|
|
|
|
7.74
|
|
$1.89 - $3.40
|
|
|
90,275
|
|
|
|
2.51
|
|
|
|
6.76
|
|
$3.41 - $11.70
|
|
|
75,217
|
|
|
|
7.69
|
|
|
|
5.78
|
|
$11.71 - $11.86
|
|
|
140,269
|
|
|
|
11.79
|
|
|
|
6.58
|
|
$11.87 - $11.99
|
|
|
141,951
|
|
|
|
11.95
|
|
|
|
5.64
|
|
$12.00- $13.08
|
|
|
132,650
|
|
|
|
12.88
|
|
|
|
4.97
|
|
$13.09 - $16.40
|
|
|
135,503
|
|
|
|
15.64
|
|
|
|
3.54
|
|
$16.41 - $21.67
|
|
|
63,446
|
|
|
|
17.74
|
|
|
|
3.56
|
|
$21.68 - $22.28
|
|
|
60,700
|
|
|
|
22.28
|
|
|
|
2.67
|
|
|
|
|
1,024,529
|
|
|
$
|
10.54
|
|
|
|
5.58
|
|
|
Summary of Restricted Stock Unit Award Activity |
The following table summarizes our restricted stock unit award activity during the years ended December 31, 2016, 2015 and 2014:
|
|
|
|
|
|
Weighted
|
|
|
|
Number
|
|
|
Average
|
|
|
|
of
|
|
|
Grant Date
|
|
|
|
Shares
|
|
|
Fair Value
|
|
Balance, January 1, 2014
|
|
|
356,589
|
|
|
$
|
12.06
|
|
Granted
|
|
|
814,800
|
|
|
|
6.48
|
|
Vested
|
|
|
(199,887
|
)
|
|
|
7.00
|
|
Forfeited or expired
|
|
|
(291,301
|
)
|
|
|
10.93
|
|
Balance, December 31, 2014
|
|
|
680,201
|
|
|
$
|
7.34
|
|
Granted
|
|
|
249,775
|
|
|
|
1.92
|
|
Vested
|
|
|
(269,401
|
)
|
|
|
8.08
|
|
Forfeited or expired
|
|
|
(19,816
|
)
|
|
|
7.27
|
|
Balance, December 31, 2015
|
|
|
640,759
|
|
|
$
|
4.92
|
|
Granted
|
|
|
—
|
|
|
|
—
|
|
Vested
|
|
|
(217,296
|
)
|
|
|
5.23
|
|
Forfeited or expired
|
|
|
(170,242
|
)
|
|
|
5.07
|
|
Balance, December 31, 2016
|
|
|
253,221
|
|
|
$
|
4.56
|
|
|
Summary of Outstanding Warrants |
The following is a summary of outstanding warrants to purchase common stock at December 31, 2016:
|
|
Total
|
|
|
|
|
|
|
|
|
|
Outstanding
|
|
|
Exercise
|
|
|
|
|
|
and
|
|
|
price per
|
|
|
|
|
|
Exercisable
|
|
|
Share
|
|
|
Expiration Date
|
(1) Series A Warrants issued in July 2014 financing
|
|
|
2,779,933
|
|
|
|
4.00
|
|
|
July 2019
|
(2) Series B Warrants issued in July 2014 financing
|
|
|
670,269
|
|
|
|
4.00
|
|
|
July 2019
|
(3) Series A-1 Warrants issued in April 2015 financing
|
|
|
239,234
|
|
|
|
2.40
|
|
|
October 2020
|
|
Summary of Fair Value of Warrants Issued |
The estimated fair value of warrants issued and classified as liabilities is reassessed at each reporting date using the Black-Scholes option pricing model.
|
|
As of
|
|
|
|
December 31,
|
|
Series A and Series B Warrant Valuation Assumptions
|
|
2016
|
|
|
2015
|
|
Risk-free interest rates
|
|
|
1.33
|
%
|
|
|
1.42
|
%
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected life
|
|
2.50 years
|
|
|
3.50 years
|
|
Expected volatility
|
|
|
95
|
%
|
|
|
77
|
%
|
|
Computation of Basic and Diluted Net Loss Attributable to Common Shareholders Per Share |
The following table presents the computation of basic and diluted net loss attributable to common stockholders per share (in thousands, except per share and share amounts):
|
|
Years ended December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
Numerator
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(20,129
|
)
|
|
$
|
(16,801
|
)
|
|
$
|
(26,240
|
)
|
Denominator
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
29,949,432
|
|
|
|
26,147,344
|
|
|
|
18,098,799
|
|
Basic and diluted net loss per common share
|
|
$
|
(0.67
|
)
|
|
$
|
(0.64
|
)
|
|
$
|
(1.45
|
)
|
|